Literature DB >> 34498108

Smoldering lesions in MS: if you like it then you should put a rim on it.

Catarina Pinto1,2, Melissa Cambron3, Adrienn Dobai4,5, Eva Vanheule2,6, Jan W Casselman7,8,9.   

Abstract

PURPOSE: In multiple sclerosis (MS), chronic active/smoldering white matter lesions presenting with hypointense rims on susceptibility-weighted imaging (SWI) of the brain have been recognized as an important radiological feature. The aim of this work was to study the prevalence of paramagnetic rim lesions (RLs) in MS patients in a clinical setting and to assess differences in demographic and clinical variables regarding the presence of RLs.
METHODS: All 3 T brain magnetic resonance (MR) studies performed in MS patients between July 2020 and January 2021 were reviewed. In all patients, RLs were assessed on three-dimensional (3D) SWI images and the T2 FLAIR lesion load volume was assessed. Demographic, laboratory (oligoclonal bands in CSF), and clinical data, including functional status with Expanded Disability Status Scale (EDSS), were retrieved from the clinical files.
RESULTS: Of the 192 patients, 113 (59%) presented with at least 1 RL. In the RL-positive group, the mean RL count was 4.81 ranging from 1 to 37. There was no significant difference in the number of RLs between the different types of MS (p = 0.858). Regarding the presence of RLs, there were no significant differences based on gender (p = 0.083), disease duration (p = 0.520), treatment regime (p = 0.326), EDSS score (p = 0.103), and the associated T2 FLAIR lesion load volume.
CONCLUSION: SWI RLs were frequently detected in our cohort regardless of the MS type, T2 FLAIR lesion load volume, demographic features, disease duration, or clinical score. Our results suggest that RLs are not associated with more severe forms of the disease. Today, RLs can be seen on 3 T 3D SWI, although this is not a clinical standard sequence yet. Therefore, it should be considered an additional helpful MR sequence in the diagnostic workup of MS, although more studies are warranted to establish the role of RLs as prognostic markers.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  MR; Multiple sclerosis; Ring lesions; SWI

Mesh:

Year:  2021        PMID: 34498108     DOI: 10.1007/s00234-021-02800-0

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  39 in total

Review 1.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

2.  Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.

Authors:  S Chawla; I Kister; J Wuerfel; J-C Brisset; S Liu; T Sinnecker; P Dusek; E M Haacke; F Paul; Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-24       Impact factor: 3.825

3.  Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.

Authors:  Martina Absinta; Pascal Sati; Federica Masuzzo; Govind Nair; Varun Sethi; Hadar Kolb; Joan Ohayon; Tianxia Wu; Irene C M Cortese; Daniel S Reich
Journal:  JAMA Neurol       Date:  2019-12-01       Impact factor: 18.302

4.  Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.

Authors:  D M Harrison; X Li; H Liu; C K Jones; B Caffo; P A Calabresi; P van Zijl
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-03       Impact factor: 3.825

5.  Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process.

Authors:  Martina Absinta; Pascal Sati; María I Gaitán; Pietro Maggi; Irene C M Cortese; Massimo Filippi; Daniel S Reich
Journal:  Ann Neurol       Date:  2013-09-16       Impact factor: 10.422

6.  Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.

Authors:  Josa M Frischer; Stephen D Weigand; Yong Guo; Nilufer Kale; Joseph E Parisi; Istvan Pirko; Jay Mandrekar; Stephan Bramow; Imke Metz; Wolfgang Brück; Hans Lassmann; Claudia F Lucchinetti
Journal:  Ann Neurol       Date:  2015-08-24       Impact factor: 10.422

7.  Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty.

Authors:  Margareta A Clarke; Amal Pr Samaraweera; Yasser Falah; Alain Pitiot; Christopher M Allen; Robert A Dineen; Chris R Tench; Paul S Morgan; Nikos Evangelou
Journal:  Mult Scler       Date:  2019-10-31       Impact factor: 6.312

Review 8.  Diagnosis and Treatment of Multiple Sclerosis: A Review.

Authors:  Marisa P McGinley; Carolyn H Goldschmidt; Alexander D Rae-Grant
Journal:  JAMA       Date:  2021-02-23       Impact factor: 56.272

9.  Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

Authors:  Assunta Dal-Bianco; Günther Grabner; Claudia Kronnerwetter; Michael Weber; Romana Höftberger; Thomas Berger; Eduard Auff; Fritz Leutmezer; Siegfried Trattnig; Hans Lassmann; Francesca Bagnato; Simon Hametner
Journal:  Acta Neuropathol       Date:  2016-10-27       Impact factor: 17.088

Review 10.  Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.

Authors:  Massimo Filippi; Paolo Preziosa; Brenda L Banwell; Frederik Barkhof; Olga Ciccarelli; Nicola De Stefano; Jeroen J G Geurts; Friedemann Paul; Daniel S Reich; Ahmed T Toosy; Anthony Traboulsee; Mike P Wattjes; Tarek A Yousry; Achim Gass; Catherine Lubetzki; Brian G Weinshenker; Maria A Rocca
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

View more
  2 in total

1.  Diagnostic Value of Magnetic Resonance Susceptibility-Weighted Imaging Scanning in Different Types of Early Prostate Cancer.

Authors:  Ruihui Gao; Jiayuan Liu; Hengcheng Zhu
Journal:  Scanning       Date:  2022-05-23       Impact factor: 1.750

Review 2.  Predictive MRI Biomarkers in MS-A Critical Review.

Authors:  Vlad Eugen Tiu; Iulian Enache; Cristina Aura Panea; Cristina Tiu; Bogdan Ovidiu Popescu
Journal:  Medicina (Kaunas)       Date:  2022-03-03       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.